After cardiovascular diseases and oncological pathologies, type 2 diabetes is the most common direct cause of human mortality. Unfortunately, till now experts have not invented the methods, allowing to completely eliminate this dangerous progressive disease. But scientists are constantly looking for effective techniques to control the course of the pathology, offering patients something new in the treatment of type 2 diabetes. Recent studies are very encouraging, as they increase the chances of getting rid of the need for lifelong medication.
New treatments for type 2 diabetes
A particular feature of the disease under consideration is the partial or total resistance (stability) of the organism to insulin. Therefore, the main goal of therapy is to increase the sensitivity to this hormone.
At early stages of diabetes development, it is enough to control body weight, adhere to a special diet and increase the amount of exercise. These measures can effectively reduce the concentration of glucose in the blood , prevent complications of pathology.
Severe forms of the disease involve taking drugs, courses or for life. New technologies for the treatment of non-insulin-dependent diabetes mellitus type 2 can not only increase the susceptibility of tissues and cells of the body to insulin and effectively reduce blood sugar, but also prevent the progression of pathology at the pre-diabetes stage, when, in fact, the ailment is just beginning to develop.
New drugs in the treatment of type 2 diabetes mellitus
The most modern drugs for treating the described pathology are:
1. Insulin sensitizers or glitazones:
- Avandia;
- Aktos.
2. Incremental mimetics:
- Baeta;
- Victoria.
3. Meglitinides:
- Starlix;
- Novonorm.
4. DPP-4 inhibitors:
- Januvia;
- Galvus.
5. Combined preparations:
- Avandamet;
- Glybometh;
- Avandaglim;
- Galvus-Met.
The appointment of any funds should be handled only by an endocrinologist.